Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Immuno-oncology
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Immuno-oncology
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Immuno-oncology
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Immuno-oncology
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Therapy areas
Immuno-oncology
Immuno-oncology
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-oncology
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
Biospace News
-
January 11, 2021
Immuno-oncology
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA – FirstWord Pharma
Immuno-oncology
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint Data to NUBEQA (darolutamide) Prescribing Information – FirstWord Pharma
Immuno-oncology
Greenwich LifeSciences to Participate in Multiple Virtual Investor Conferences During 2021 JP Morgan Healthcare Week
Immuno-oncology
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program Nasdaq:CMRX
Immuno-oncology
Starting the Year Dropping Cash – Two Companies Scooped Up This...
Biospace News
-
January 8, 2021
0
Immuno-oncology
BioSpace Movers & Shakers, Jan. 8
Biospace News
-
January 8, 2021
0
Immuno-oncology
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program
Biospace News
-
January 8, 2021
0
Immuno-oncology
Constellation Pharmaceuticals Appoints Brendan Delaney as Chief Commercial Officer Nasdaq:CNST
Globenewswire News
-
January 7, 2021
0
Immuno-oncology
Biopharma Investments Strong in the First Week of 2021
Biospace News
-
January 7, 2021
0
1
2
3
...
77
Page 1 of 77
- Advertisement -
MOST POPULAR
Celyad to Present Update on allogeneic and autologous NKG2D-based CAR-T Candidates...
April 17, 2019
Roche and the pan-Canadian Pharmaceutical Alliance (pCPA) Complete Negotiations for Multiple...
March 19, 2019
FibroGen Names Enrique Conterno as Chief Executive OfficerConterno brings global pharmaceutical...
January 6, 2020
Emmaus Life Sciences Announces a New Adherence Program for Its Sickle...
January 6, 2020
Load more
HOT NEWS
Others
Resolve Therapeutics to Present Phase II Data on Lead Product Candidate...
Commercial
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Deals
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy...
Clinical
FDA In Brief: FDA issues warning letter for products illegally marketed...
